Change history
17 February 2022
The image was tagged in XML incorrect as MediaInlineImage.
References
Lee WK, Iida T, Ogura Y, Chen SJ, Wong TY, Mitchell P, et al. Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET Study: a randomized clinical trial. JAMA Ophthalmol. 2018;136:786–93. https://doi.org/10.1001/jamaophthalmol.2018.1804
Wong TY, Ogura Y, Lee WK, Iida T, Chen SJ, Mitchell P, et al. Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy: two-year results of the aflibercept in polypoidal choroidal vasculopathy study. Am J Ophthalmol. 2019;204:80–9. https://doi.org/10.1016/j.ajo.2019.02.027
Author information
Authors and Affiliations
Contributions
SS, CHV, KT, and GC developed the infographic design. CHV prepared the infographic. GC, SS, KT, PL, CZS, and RG edited and reviewed the infographic and provided the scientific expert advice.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sim, S.S., Vyas, C.H., Gunatheesan, R. et al. Infographic: “Planet Trial: Intravitreal aflibercept monotherapy for polypoidal choroidal vasculopathy (PCV)”. Eye 36, 1142 (2022). https://doi.org/10.1038/s41433-021-01874-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41433-021-01874-7
